Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Niels de Fine Olivarius a Central Research
Unit and Department of General Practice, University of Copenhagen,
Panum Institute, DK-2200, Copenhagen, Denmark, b Medical Department M, Odense
University Hospital, University of Southern Denmark, DK-5000 Odense,
Denmark, c Department of Biostatistics, Institute of Public
Health, University of Copenhagen, Panum Institute, d Department of Clinical
Biochemistry, Odense University Hospital, University of Southern
Denmark
Correspondence to: N deF Olivarius
no{at}gpract.ku.dk
Objective:
To assess the effect of a multifaceted
intervention directed at general practitioners on six year mortality,
morbidity, and risk factors of patients with newly diagnosed type 2 diabetes.
What is already known on this topic
What this study adds
Design:
Pragmatic, open, controlled trial with
randomisation of practices to structured personal care or routine care;
analysis after 6 years.
Setting:
311 Danish practices with 474 general
practitioners (243 in intervention group and 231 in comparison group).
Participants:
874 (90.1%) of 970 patients aged
40
years who had diabetes diagnosed in 1989-91 and survived until six year follow up.
Intervention:
Regular follow up and individualised
goal setting supported by prompting of doctors, clinical guidelines, feedback, and continuing medical education.
Main outcome measures:
Predefined clinical non-fatal
outcomes, overall mortality, risk factors, and weight.
Results:
Predefined non-fatal outcomes and mortality were the same in both groups. The following risk factor levels were
lower for intervention patients than for comparison patients (median
values): fasting plasma glucose concentration (7.9 v 8.7 mmol/l, P=0.0007), glycated haemoglobin (8.5% v 9.0%,
P<0.0001; reference range 5.4-7.4%), systolic blood pressure (145 v 150 mm Hg, P=0.0004), and cholesterol concentration (6.0 v 6.1 mmol/l, P=0.029, adjusted for baseline concentration).
Both groups had lost weight since diagnosis (2.6 v 2.0 kg).
Metformin was the only drug used more frequently in the intervention
group (24% (110/459) v 15% (61/415)).Intervention doctors
arranged more follow up consultations, referred fewer patients to
diabetes clinics, and set more optimistic goals.
Conclusions:
In primary care, individualised goals
with educational and surveillance support may for at least six years bring risk factors of patients with type 2 diabetes to a level that has
been shown to reduce diabetic complications but without weight gain.
Evidence is increasing that control of hyperglycaemia, hypertension,
and dyslipidaemia may postpone the development of diabetic
complications in patients with type 2 diabetes
Structured individualised personal care with educational and
surveillance support for general practitioners reduced levels of risk
factors in type 2 diabetic patients after six years
Read all Rapid Responses